Cocrystal Pharma, Inc.
Pharmaceutical company · Bothell, Washington, United States · Nasdaq: COCP
Cocrystal Pharma, Inc. is a pharmaceutical company headquartered in Bothell, Washington, United States. Its shares trade on Nasdaq under the ticker COCP. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $498,199 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2017.
Cocrystal Pharma at a glance
What does Cocrystal Pharma do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $498,199 in total (2025).
Private fundraising reported to the SEC
15 Form D notices; the most recent reported $3 million sold (2017).
Frequently asked questions about Cocrystal Pharma
Where is Cocrystal Pharma headquartered?
Cocrystal Pharma, Inc. is headquartered in Bothell, Washington, United States.
What does Cocrystal Pharma do?
Cocrystal Pharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Cocrystal Pharma a public company?
Yes. Cocrystal Pharma, Inc. trades on Nasdaq under the ticker COCP.
Similar companies
- Immunome Inc.Bothell, Washington, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.